PRESS RELEASE published on 07/29/2025 at 14:08, 8 months 9 days ago Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted Annual General Meeting Resolutions Strategic Direction Viromed Medical AG Cold Plasma Technology
PRESS RELEASE published on 07/29/2025 at 14:00, 8 months 9 days ago Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101 Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA Eckert & Ziegler Prostate Cancer Radiopharmaceutical ART-101 Archeus
PRESS RELEASE published on 07/29/2025 at 14:00, 8 months 9 days ago Thermon(R) Introduces Poseidon(TM) and Pontus(TM) Liquid Load Banks: Revolutionizing Data Center Commissioning and Validation Thermon announces global availability of Poseidon™ and Pontus™ Liquid Load Banks for data center validation, designed for HPC environments Data Center Poséidon Thermon Liquid Load Banks Pontus
PRESS RELEASE published on 07/29/2025 at 14:00, 8 months 9 days ago bioEnergy Development Inc. Announces First Sale of Breakthrough Mobile Bioreactor for On-Site Waste-to-Energy Conversion bioEnergy Development Inc. sells first mobile bioreactor in Florida's equestrian industry, turning manure into energy and agricultural products, offering decentralized clean energy solutions Florida Waste-to-Energy Mobile Bioreactor Equestrian Industry BioEnergy Development Inc.
PRESS RELEASE published on 07/29/2025 at 14:00, 8 months 9 days ago Ovation Science Expands with Planet 13 into Florida Ovation Science expands license agreement with Planet 13 to bring Invisicare® topical cannabis products to Florida, leveraging Planet 13's extensive retail network License Agreement Planet 13 Ovation Science Florida Market Topical Products
PRESS RELEASE published on 07/29/2025 at 14:00, 8 months 9 days ago Trifecta Gold Provides Exploration Update from the Tombstone Gold Belt, Yukon Trifecta Gold provides exploration updates on Mt. Hinton and Rye projects in Yukon portion of Tombstone Gold Belt. Mt. Hinton drilling completed with 753m drilled. Rye Property granted drill permit Drilling Exploration Updates Trifecta Gold Mt. Hinton Rye Property
PRESS RELEASE published on 07/29/2025 at 13:55, 8 months 9 days ago H&R GmbH & Co. KGaA: H&R Holding GmbH Waives Minimum Acceptance Threshold in Tender Offer to Shareholders of H&R GmbH & Co. KGaA H&R Holding GmbH waives the minimum acceptance threshold in a tender offer to shareholders of H&R GmbH & Co. KGaA, providing increased transaction certainty. Shareholders can accept the offer until August 25, 2025 Shareholders Tender Offer Acceptance Threshold Transaction Certainty H&R Holding GmbH
PRESS RELEASE published on 07/29/2025 at 13:50, 8 months 9 days ago H&R Holding GmbH waives minimum acceptance threshold in public tender offer to the shareholders of H&R GmbH & Co. KGaA H&R Holding GmbH waives minimum acceptance threshold in public tender offer to the shareholders of H&R GmbH & Co. KGaA increasing transaction security and extending acceptance period until 25 August 2025 Shareholders Public Tender Offer H&R Holding GmbH Waives Minimum Acceptance Threshold
PRESS RELEASE published on 07/29/2025 at 13:30, 8 months 9 days ago Audited Annual Statements for the Fiscal Year ended March 31, 2025 Plaintree Systems Inc. releases audited financial statements for Fiscal Year 2025, reporting lower revenues and net loss. CEO highlights challenges due to geo-political factors Revenues Net Loss Plaintree Systems Inc. Audited Financial Statements Geo-political Challenges
PRESS RELEASE published on 07/29/2025 at 13:30, 8 months 9 days ago MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain MIRA Pharmaceuticals advances non-opioid oral drug Ketamir-2 for neuropathic pain, clears FDA IND for Phase 2a, demonstrates potent effects in preclinical studies FDA Preclinical Studies MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain
Published on 04/07/2026 at 15:00, 6 hours 20 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 6 hours 35 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 6 hours 40 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 6 hours 50 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 6 hours 50 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 16:32, 4 hours 48 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 4 hours 50 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 6 hours 20 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 6 hours 25 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 17:57, 3 hours 23 minutes ago Peugeot Invest publishes its 2025 Universal Registration Document
Published on 04/07/2026 at 17:45, 3 hours 35 minutes ago ENGIE accelerates the deployment of battery storage with nearly 400 MW of new projects in Europe
Published on 04/07/2026 at 17:38, 3 hours 42 minutes ago Reporting on share buyback transactions carried out between March 30 and April 2, 2026
Published on 04/07/2026 at 17:35, 3 hours 45 minutes ago Disclosure of the number of shares and the total number of voting rights as of March 31, 2026